Semler Scientific, Inc. (SMLR)

Market Cap	578.13M
Revenue (ttm)	49.23M
Net Income (ttm)	-29.88M
Shares Out	13.69M
EPS (ttm)	-3.78
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	866,124
Open	44.42
Previous Close	45.23
Day's Range	40.90 - 44.42
52-Week Range	21.77 - 81.56
Beta	1.40
Analysts	Strong Buy
Price Target	89.00 (+110.73%)
Earnings Date	Aug 4, 2025

About SMLR

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, ind...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 21, 2014
• Employees: 79
• Stock Exchange: NASDAQ
• Ticker Symbol: SMLR
• Website: https://www.semlerscientific.com

Financial Performance

In 2024, Semler Scientific's revenue was $56.29 million, a decrease of -17.44% compared to the previous year's $68.18 million. Earnings were $40.90 million, an increase of 98.70%.

Analyst Summary

According to 3 analysts, the average rating for SMLR stock is "Strong Buy." The 12-month stock price target is $89.0, which is an increase of 110.73% from the latest price.

Price Target

$89.0

(110.73% upside)

Analyst Consensus: Strong Buy